AlloVir
Developing cellular immunotherapies for severe viral infections. Learn more
Launch date
Employees
Market cap
AUD134m
Enterprise valuation
(AUD52m) (Public information from Sep 2024)
Share price
$0.79 ALVR
Lincoln Massachusetts (HQ)
Authorizing premium user...